Table 4.
Risk of biochemical recurrence by margin status and pT derived from competing risk regression models.
| Margin status and pT | Relative to pT2 clear margin |
PSM vs. clear margina |
||||
|---|---|---|---|---|---|---|
| sHR | 95% CI | p-Value | sHR | 95% CI | p-Value | |
| pT2 | ||||||
| Clear margins | 1.0 | Reference | – | 1.0 | Reference | – |
| Positive margin | 4.3 | 3.2–5.9 | <0.001 | 4.6 | 3.2–6.2 | <0.001 |
| pT3a | ||||||
| Clear margin | 2.2 | 1.7–2.9 | <0.001 | 1.0 | Reference | – |
| Positive margin | 5.5 | 4.2–7.2 | <0.001 | 2.6 | 2.0–3.3 | <0.001 |
| pT3b | ||||||
| Clear margin | 4.9 | 3.4–7.0 | <0.001 | 1.0 | Reference | – |
| Positive margin | 7.1 | 5.0–10.0 | <0.001 | 1.4 | 1.0–2.0 | 0.06 |
CI, confidence interval; sHR, sub-hazard ratio; pT, pathological tumor stage; PSM, positive surgical margin; –, not available.
Note: the “Reference” indicates that this category is the reference category.
Stratified by stage category.